Clinical Trials · NCT01524770
A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 50
- Start date
- Mar 2012
- Locations
- 1 site, United States
- Primary endpoint
- Pharmacokinetics: Area Under the Concentration Curve (AUC[0-336]) for Dulaglutide